Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Fluidwell introduces E126 explosion-proof flow computer July 11, 2018 Rockwell Automation announces Project Sherlock artificial intelligence (AI) module November 22, 2017 Special zones for making bulk drugs fail to take off August 4, 2017